MULTAQ Drug Profile, 2023 ( 2023 )
Genre(s)
MedicalMULTAQ Drug Profile, 2023
This report focuses on MULTAQ and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Annual sales revenues
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
Author
Authors: DrugPatentWatch
This book is unclaimed and was imported from external sources as part of the Dexter’s Place book search. Authors may not be members of Dexter’s Place.
If this is your book and you can submit a claim request below (login required)
Leave a Reply
You must be logged in to post a comment.